| Jan 8 2021 |
State of Ohio Board of Pharmacy Adopts Resolution Regarding Responsible Person Requirements for Licensure of Terminal Distributor and Dangerous Drugs License |
Dinsmore & Shohl LLP |
| Jan 8 2021 |
US-UK Equivalency Agreement for Organic Products Enters into Effect |
Keller and Heckman LLP |
| Jan 7 2021 |
National Advertising Division (NAD) Sides with Danone in Challenge of Chobani Comparative Sugar Claims |
Keller and Heckman LLP |
| Jan 6 2021 |
FDA Alerts Consumers to Pet Food Recalls for Potentially Fatal Levels of Aflatoxin |
Keller and Heckman LLP |
| Jan 5 2021 |
Drug Facility Fees Will Not Apply to Distilleries Producing Hand Sanitizer |
Bergeson & Campbell, P.C. |
| Jan 5 2021 |
Seventh Circuit Sides with Plaintiffs in Appeal of “100% Grated Parmesan Cheese” Claims |
Proskauer Rose LLP |
| Jan 5 2021 |
Improper CBD Product Marketing Lands in FDA’s Crosshairs |
Dinsmore & Shohl LLP |
| Jan 4 2021 |
FDA Adds Three New Substances to its Inventory of Effective FCS Notifications January 4 |
Keller and Heckman LLP |
| Jan 4 2021 |
FDA to Publish Biennial Uniform Compliance Date for 2021-2022 Food Labeling Regulations |
Keller and Heckman LLP |
| Jan 2 2021 |
Twelve Cannabis Plant Patents and Counting |
Squire Patton Boggs (US) LLP |
| Jan 1 2021 |
Federal Circuit Endorses the Doctrine of Equivalents Again for Lilly’s ALIMTA®: Different Amendment, Same Result |
Squire Patton Boggs (US) LLP |
| Dec 29 2020 |
Saga of “Most Favored Nations” |
Giordano, Halleran & Ciesla, P.C. |
| Dec 29 2020 |
Federal Courts Block Implementation of Most Favored Nation Drug Pricing Rule |
K&L Gates LLP |
| Dec 28 2020 |
Drug Testing Legislation in 2020: A Look Back |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Dec 27 2020 |
Digital Health in India: Emerging Technologies (AI and 3D printing) [Podcast] |
Nishith Desai Associates |
| Dec 25 2020 |
Intellectual Property Issues in the Indian Pharmaceutical Sector: Patents |
Nishith Desai Associates |
| Dec 24 2020 |
Advertisement and Promotion of Drugs and Medical Devices to Healthcare Practitioners in India |
Nishith Desai Associates |
| Dec 23 2020 |
EEOC Guidance Regarding COVID-19 Vaccinations |
Faegre Drinker |
| Dec 23 2020 |
Direct to Consumer Advertisement and Promotion of Drugs and Medical Devices in India [Podcast] |
Nishith Desai Associates |
| Dec 23 2020 |
FDA Issues Warning Letter to Whole Foods for Pattern of Undeclared Allergens |
Keller and Heckman LLP |
| Dec 23 2020 |
FDA in 2020: What a Year! (Part 3 of 3) |
Mintz |
| Dec 22 2020 |
340b Update: Recent Supreme Court Ruling May Curtail 340b Program Discriminatory Pricing |
K&L Gates LLP |
| Dec 22 2020 |
FDA Proposes to Revoke Standard of Identity for French Dressing |
Keller and Heckman LLP |
| Dec 22 2020 |
FDA in 2020: What a Year! (Part 2 of 3) |
Mintz |
| Dec 21 2020 |
An Early Holiday Present for Generics? Legislation Requiring Greater Disclosure by Brands Passes the Senate |
McDermott Will & Schulte LLP |
| Dec 21 2020 |
Top Five Drug and Device Developments of 2020 |
Faegre Drinker |
| Dec 21 2020 |
Restrictions on Venue in Hatch-Waxman Litigation |
Epstein Becker & Green, P.C. |
| Dec 21 2020 |
Round Two - FDA Issues Emergency Use Authorization for Moderna’s COVID-19 Vaccine |
Foley & Lardner LLP |
| Dec 21 2020 |
FDA Guidance: Use of “Potassium Salt” as an Alternate Name for “Potassium Chloride” in Food Labeling |
Keller and Heckman LLP |
| Dec 21 2020 |
Election 2020 Putting Cannabis Center Stage |
Squire Patton Boggs (US) LLP |
| Dec 21 2020 |
Launching a Drug or Medical Device in India: From Clinical Trial to Sale [PODCAST} |
Nishith Desai Associates |
| Dec 19 2020 |
EPA Announces New Policy for Registrants Voluntarily to Disclose Inert Ingredients in Antimicrobial Products |
Bergeson & Campbell, P.C. |
| Dec 18 2020 |
FDA Proposes Revocation of Frozen Cherry Pie Standards of Identity and Quality |
Keller and Heckman LLP |
| Dec 18 2020 |
Introduction to the Pharma & Healthcare Podcast Series [PODCAST] |
Nishith Desai Associates |
| Dec 17 2020 |
New Administration Could Provide Ideal Backdrop for Tribes Entering Cannabis Industry |
Van Ness Feldman LLP |
